RACISBGPOIPUKD-UHFFFAOYSA-N
C32H26Cl3F3N8O — CID 123167278
Data last refreshed: (MolForge compound catalog, from PubChem)
About RACISBGPOIPUKD-UHFFFAOYSA-N
RACISBGPOIPUKD-UHFFFAOYSA-N (PubChem CID 123167278) has the molecular formula C32H26Cl3F3N8O and a molecular weight of 701.97 g/mol. Its IUPAC name is N-[7-[5-chloro-4-[6-[[6-(2,5-dichloro-4-pyridinyl)-5-methyl-3-pyridinyl]methyl]-3,5-dimethyl-2-pyridinyl]-2-pyridinyl]-6,8-dihydro-5H-imidazo[1,2-a]pyrazin-2-yl]-2,2,2-trifluoroacetamide.
Molecular Properties
| Compound Name | RACISBGPOIPUKD-UHFFFAOYSA-N |
|---|---|
| PubChem CID | 123167278 |
| Molecular Formula | C32H26Cl3F3N8O |
| Molecular Weight | 701.97 g/mol |
| Exact Mass | 700.12 |
| IUPAC Name | N-[7-[5-chloro-4-[6-[[6-(2,5-dichloro-4-pyridinyl)-5-methyl-3-pyridinyl]methyl]-3,5-dimethyl-2-pyridinyl]-2-pyridinyl]-6,8-dihydro-5H-imidazo[1,2-a]pyrazin-2-yl]-2,2,2-trifluoroacetamide |
| SMILES | Cc1cc(C)c(-c2cc(N3CCn4cc(NC(=O)C(F)(F)F)nc4C3)ncc2Cl)nc1Cc1cnc(-c2cc(Cl)ncc2Cl)c(C)c1 |
| InChI | InChI=1S/C32H26Cl3F3N8O/c1-16-6-17(2)30(42-24(16)8-19-7-18(3)29(41-11-19)20-9-25(35)39-12-22(20)33)21-10-27(40-13-23(21)34)46-5-4-45-14-26(43-28(45)15-46)44-31(47)32(36,37)38/h6-7,9-14H,4-5,8,15H2,1-3H3,(H,44,47) |
| InChIKey | RACISBGPOIPUKD-UHFFFAOYSA-N |
| XLogP | 7.79 |
| TPSA | 101.72 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 47 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 701.97 |
| LogP ≤ 5 | 7.79 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 8 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': '2-halo_pyridine', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 123167278 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.